OBJECTIVE: To determine whether preadolescent children with hemifacial microsomia (HFM) have higher risk of neurodevelopmental delays than unaffected control individuals. DESIGN: Case-control follow-up study of neurodevelopment in children with and without HFM. SETTING: Case individuals were originally recruited from 26 craniofacial centers across the United States and Canada, and controls were recruited through community pediatricians. PARTICIPANTS: One hundred thirty-six children with HFM (cases) and 568 unaffected children (controls). Main Exposure History of HFM. MAIN OUTCOME MEASURES: The Peabody Picture Vocabulary Test-Third Edition, the Beery-Buktenica Developmental Test of Visual Motor Integration-Fifth Edition, and the Academic Competence scales from the Child Behavior Checklist and the Teacher Report Form. RESULTS: Children with HFM scored lower than controls on all measures (effect size = -0.27 to -0.45; P < .001 to P = .008). Compared with controls, cases were 2 to 3 times as likely to score in the at-risk range. Relative to controls, outcomes were worse for male cases and those whose mothers were 25 years or younger at the time of their birth. Cases with HFM plus other malformations had poorer outcomes, as did cases with hearing, vision, or speech impairments. CONCLUSIONS: This is the first study, to our knowledge, to show that children with HFM have poorer neurodevelopmental outcomes than unaffected children, but further study using more detailed assessments is indicated. Clinically, the findings suggest that early neurodevelopmental screening is warranted for all children with HFM.
OBJECTIVE: To determine whether preadolescent children with hemifacial microsomia (HFM) have higher risk of neurodevelopmental delays than unaffected control individuals. DESIGN: Case-control follow-up study of neurodevelopment in children with and without HFM. SETTING: Case individuals were originally recruited from 26 craniofacial centers across the United States and Canada, and controls were recruited through community pediatricians. PARTICIPANTS: One hundred thirty-six children with HFM (cases) and 568 unaffected children (controls). Main Exposure History of HFM. MAIN OUTCOME MEASURES: The Peabody Picture Vocabulary Test-Third Edition, the Beery-Buktenica Developmental Test of Visual Motor Integration-Fifth Edition, and the Academic Competence scales from the Child Behavior Checklist and the Teacher Report Form. RESULTS:Children with HFM scored lower than controls on all measures (effect size = -0.27 to -0.45; P < .001 to P = .008). Compared with controls, cases were 2 to 3 times as likely to score in the at-risk range. Relative to controls, outcomes were worse for male cases and those whose mothers were 25 years or younger at the time of their birth. Cases with HFM plus other malformations had poorer outcomes, as did cases with hearing, vision, or speech impairments. CONCLUSIONS: This is the first study, to our knowledge, to show that children with HFM have poorer neurodevelopmental outcomes than unaffected children, but further study using more detailed assessments is indicated. Clinically, the findings suggest that early neurodevelopmental screening is warranted for all children with HFM.
Authors: Sarah McCue Horwitz; Julia R Irwin; Margaret J Briggs-Gowan; Joan M Bosson Heenan; Jennifer Mendoza; Alice S Carter Journal: J Am Acad Child Adolesc Psychiatry Date: 2003-08 Impact factor: 8.829
Authors: Henriëtte F N Swanenburg de Veye; Frits A Beemer; Gideon J Mellenbergh; Wim H G Wolters; Josien A Heineman-de Boer Journal: Cleft Palate Craniofac J Date: 2003-05
Authors: Michael Rutter; Avshalom Caspi; David Fergusson; L John Horwood; Robert Goodman; Barbara Maughan; Terrie E Moffitt; Howard Meltzer; Julia Carroll Journal: JAMA Date: 2004-04-28 Impact factor: 56.272
Authors: Martha M Werler; Jane E Sheehan; Catherine Hayes; Allen A Mitchell; John B Mulliken Journal: Birth Defects Res A Clin Mol Teratol Date: 2004-06
Authors: Daniela V Luquetti; Matthew L Speltz; Erin R Wallace; Babette Siebold; Brent R Collett; Amelia F Drake; Alexis L Johns; Kathleen A Kapp-Simon; Sara L Kinter; Brian G Leroux; Leanne Magee; Susan Norton; Kathleen Sie; Carrie L Heike Journal: Cleft Palate Craniofac J Date: 2019-01-08
Authors: Lynette M Dufton; Matthew L Speltz; Judith P Kelly; Brian Leroux; Brent R Collett; Martha M Werler Journal: J Pediatr Psychol Date: 2011-02-23
Authors: Matthew L Speltz; Erin R Wallace; Brent R Collett; Carrie L Heike; Daniela V Luquetti; Martha M Werler Journal: Plast Reconstr Surg Date: 2017-09 Impact factor: 4.730
Authors: Matthew L Speltz; Kathleen A Kapp-Simon; Alexis L Johns; Erin R Wallace; Brent R Collett; Leanne Magee; Brian G Leroux; Daniela V Luquetti; Carrie L Heike Journal: J Pediatr Date: 2018-04-22 Impact factor: 4.406
Authors: Daniela V Luquetti; Michelle R Brajcich; Nicola M Stock; Carrie L Heike; Alexis L Johns Journal: Int J Pediatr Otorhinolaryngol Date: 2018-02-07 Impact factor: 1.675
Authors: Samantha E Parker; Jacqueline R Starr; Brent R Collett; Matthew L Speltz; Martha M Werler Journal: Paediatr Perinat Epidemiol Date: 2014-10-18 Impact factor: 3.980
Authors: Brent R Collett; Kathy Chapman; Erin R Wallace; Sara L Kinter; Carrie L Heike; Matthew L Speltz; Martha Werler Journal: Am J Speech Lang Pathol Date: 2019-10-03 Impact factor: 2.408
Authors: Alexis L Johns; Daniela V Luquetti; Michelle R Brajcich; Carrie L Heike; Nicola M Stock Journal: J Craniofac Surg Date: 2018-11 Impact factor: 1.046